A new CRISPR startup is betting regulators will ease up on gene-editing
Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU.
9 Jan 11:00 · MIT Technology Review
A new CRISPR startup is betting regulators will ease up on gene-editing
Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU.
9 Jan 11:00 · MIT Technology Review
Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments
Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases.
9 Jan 11:00 · WIRED
Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments
Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases.
9 Jan 11:00 · WIRED
Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments
Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases.
9 Jan 11:00 · WIRED
last updated on 10 Jan 08:10